Focus Stocks
Is Mastercard Ready for a Rest?
Published on Thursday, 09 February 2012 06:12 Written by TradersHuddle Wire
New York, February 9th (TradersHuddle.com) - Shares of MasterCard, Inc. (NYSE:MA) closed the trading day at $394.91 well above its calculated resistance at $354.94, which was calculated from a peak and throughs algorithm, making traders worry about a possible pull back in the stock price.
MasterCard, Inc. (NYSE:MA) is a global payment solutions company that provides a variety of services in support of the credit, debit and related payment programs of financial institutions. The Company offers transaction processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks.
Mastercard's stock broke out of its defined range that had support at $336.26 and resistance at $354.94. Now the stock is working on developing a new trading range, which should be defined by the high setup after this breakout and its probable support, which could be its previous resistance level $354.94.
From a technical perspective traders should wait to establish a position in Mastercard until a base in the stock develops that can provide good reference points to the upside and most importantly to the downside, for traders have a risk reference point before entering into a position on Mastercard stock.
Related Articles
- Above Resistance: Mastercard
- Trading Idea: - Is Mastercard close to Resistance?
- Rentrak And MasterCard Collaborate To Bring Improved Media Planning And Buying Analytics To TV Advertisers
- Approaching Support: Mastercard
- Trading the Setup In Mastercard
- MasterCard to Foster Industry Collaboration in Preparation for EMV Migration
- Mastercard - Above Average Volume Detected
- Trade Alert - Mastercard High Volume
- Mastercard Broke Support
- Is Mastercard Expecting Resistance Soon?
Related Partner Headlines
- MasterCard Believes General Court in Luxembourg's Judgment on Interchange Fees Will Ultimately Make Payments More Expensive For Consumers - Benzinga
- MasterCard Incorporated (MA): Today's Featured Diversified Services Winner - TheStreet.com
- UPDATE: Goldman Sachs Reduces PT to $475 on Mastercard on Lower Multiple - Benzinga
- MasterCard Incorporated (MA): Today's Featured Diversified Services Loser - TheStreet.com
- MasterCard Incorporated (MA): Today's Featured Diversified Services Loser - TheStreet.com
- MasterCard Gets Nod Over Visa From Guggenheim - TheStreet.com
- UPDATE: Deutsche Bank Raises PT to 515 on MasterCard; Solid Quarter - Benzinga
- UPDATE: J.P. Morgan Lowers Mastercard's PT - Benzinga
- MasterCard Incorporated (MA): Today's Featured Diversified Services Loser - TheStreet.com
- MasterCard Profits Jump 25% - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









